AOBO Launches YuYeQingHuo Capsules

American Oriental Bioengineering (AOBO) has launched a new over-the-counter (OTC) product – YuYeQingHuo Capsules (YYQH). YYQH will be manufactured by the company’s Boke subsidiary. It will be marketed throughout China utilizing AOBO’s distribution network, including the company’s national hospital and pharmacy distribution network.

Reportedly, YYQH capsule is a plant-based OTC medicine used to alleviate pain and inflammation related to laryngitis, acute pharyngitis and acute aphonia. AOBO believes that the market to address laryngitis-related symptoms is currently underserved.

Tony Liu, chairman and CEO of AOBO, said: “We are pleased to demonstrate our new product launch capabilities today. This is particularly important as we navigate the changing regulatory landscape in China. We are also excited about today’s launch because the YYQH capsules further enhance our Boke products and brand and we believe that our YYQH capsules address a niche market with no clear market leader as of now. We remain confident in our future growth prospects as we continue to expand our product lines and launch innovative new products.”